About Us
Groupe de Recherche Interdisciplinaire sur les Biomatériaux Ostéo-articulaires Injectables (GRIBOI) at first a local French organization led by Dr. Hervé Deramond, pioneer and founder of vertebroplasty.
Dedicated to improving the design, synthesis, characterization, handling and clinical use of injectable biomaterials for the treatment and/or prevention of bone and joint diseases, and to support all research and development activities that may improve the current knowledge and clinical outcomes.
Our Board of Directors
Stefano Marcia
MD
President
Italy
Marc Bohner
PhD EPFL, PhD h.c. U. Uppsala, FBSE
Honorary President
Switzerland
Jean-Michel Bouler
MSc, PHD
Vice-President (Europe)
France
Jiang Chang
PhD, FBSE, FRSC, AIMBE Fellow
Vice-President (Asia)
China
Sean Tutton
MD, FSIR, FCIRSE
Vice-President (America)
United States of America
Gamal Baroud
PhD
Vice-President (Annual Meetings)
Canada
Malin Nilsson
MSc, PhD
Secretary
Sweden
Olivier Clerk-Lamalice
MD, MSc, FRCPC, FIPP
Treasurer
Canada
Our Local Organizers
William Lu
Hong Kong
Haobo Pan
Shenzhen
Zhuofan Chen
Guangzhou
Jukka Matinlinna
Hong Kong
Alex Kelekis
Greece
Nikos Mattheos
Hong Kong
MISSION
Advancing the Field
We focus on improving the design, synthesis, characterization, and clinical application of these materials to enhance treatments for bone and joint diseases. By supporting research and development efforts, we aim to contribute to better clinical outcomes.
VISION
Effective and Accessible
We envision a future where innovative biomaterials lead to more effective and accessible treatments for bone and joint conditions. Through collaboration and cutting-edge research, we strive to set new standards in the field and improve the quality of life for patients worldwide.
PARTNERSHIPS
Stronger Together
To achieve our mission, GRIBOI works closely with institutional and private partners. By fostering collaborations across sectors, we aim to drive advancements in biomaterials and ensure the latest innovations are applied in clinical practice.
RESEARCH
Innovation at our Core
Our focus includes developing advanced experimental models, improving characterization methods for both lab and clinical testing, and promoting the dissemination of scientific knowledge. We are committed to pushing the boundaries of biomaterial science for the benefit of global healthcare.
Scientific Program Committee
Nureddin Ashammakhi
United States of America
Douglas Beall
United States of America
Stephan Becker
Austria
Alan Brook
United States of America
François Cornelis
France
Hervé Deramond
France
Frank Facchini
United States of America
Dimitrios Filippiadis
Greece
Bassem Georgy
United States of America
Scott Guelcher
United States of America
Wouter Habraken
Germany
Joshua Hirsch
United States of America
Pascal Janvier
France
Joseph Lane
United States of America
William Lee
United States of America
William Lu
H.K./China
Peter Munk
Canada
Kieran Murphy
Canada
Malin Nilsson
Spain
Pierre Weiss
France
Steven Yevich
United States of America
Our Committee Leaders
William Lu
Congress Committee
Haobo Pan
Donor Committee
Zhuofan Chen
Donor Committee
Jukka Matinlinna
Bylaws Committee
Alex Kelekis
Bylaws Committee
Nikos Mattheos
Bylaws Committee
Nikos Mattheos
Liaison Committee
Nikos Mattheos
Liaison Committee
Nikos Mattheos
Liaison Committee
Our Honorary Members
Congress Committee
Prof. Hervé Deramont
Donor Committee
Prof. Pierre Hardouin
Donor Committee
Prof. Patrick Sharrock
Bylaws Committee
Prof. Hervé Leclet
Bylaws Committee
Prof. Bernard Duquesnoy
Bylaws Committee